Market Overview:
The global hemostasis diagnostics market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bleeding disorders, rising demand for point-of-care testing systems, and technological advancements in hemostasis diagnostics. The global hemostasis diagnostics market is segmented on the basis of type into laboratory analyzers and point-of-care testing systems. The laboratory analyzers segment is further subsegmented into coagulation analyzers, platelet function analyzers, and others. The point-of-care testing systems segment is further subsegmented into thromboelastography (TEG) devices, thrombin time (TT) devices, activated partial thromboplastin time (aPTT) devices, prothrombin time/international normalized ratio (PT/INR) devices, fibrinogen tests kits & reagents), and others. On the basis of application, the global hemostasis diagnostics market is divided into hospitals laboratories & clinics; diagnostic centers; research institutes; blood banks & transfusion centers; pharmaceutical companies; medical device manufacturers; contract research organizations (CROs); and other end users such as home care settings and veterinary clinics).
Product Definition:
Hemostasis diagnostics is a medical specialty that deals with the diagnosis and treatment of disorders of blood clotting. It is important because it helps to identify and treat conditions that may lead to excessive bleeding or clotting.
Laboratory Analyzers:
Laboratory analyzers are instruments that are used to measure the concentration of blood components such as RBC, WBC and platelets. These devices work on the principle of centrifugation and separation by density. The most commonly used laboratory analyzers in hemostasis diagnostics market include automated clinical laboratories (ACLs), hematology departments, central laboratories, diagnostic centers for medical research & development (CRD)and commercial organizations.
Point-of-Care Testing Systems:
Point-of-care testing systems are devices used in hemostasis diagnostics which help in detecting the presence of a range of biomarkers, pathogens and other foreign particles. These tests are used for immediate results and can be performed by healthcare professionals at the time of care giving. The major application areas include emergency medicine, home care settings, hospitals & clinics among others.
Application Insights:
Based on the application, the market is segmented into hospitals, diagnostic centers and others. Hospitals held the largest share in 2017 owing to an increase in demand for blood tests to diagnose conditions such as stroke and heart attacks. According to a study published by NCBI, around 20% of all hospital admissions are due to cardiovascular diseases (CVDs). Thus, increasing number of CVDs will lead to an increase in demand for hemostasis diagnostics over the forecast period.
Diagnostic centers are expected register significant growth during the forecast period owing to a rise in prevalence of chronic diseases such as cancer that require regular checkups and blood tests at these centers. Furthermore, rising awareness about early diagnosis is anticipated fuel product adoption at these centers over the coming years. Other applications include primary healthcare facilities/family medicine clinics and laboratories acting as part of a national network or within regional networks (such as Intermountain Healthcare Laboratories).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and increasing prevalence of chronic diseases in this region. Moreover, favorable reimbursement policies are also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure and improving infrastructure in developing countries such as India and China. In addition, growing awareness about blood disorders among people is also expected favorably impact regional demand for hemostasis diagnostics during the same period.
Growth Factors:
- Increasing incidence of bleeding disorders: The global hemostasis diagnostics market is expected to grow at a CAGR of 7.5% from 2016 to 2021, owing to the increasing incidence of bleeding disorders such as hemophilia and von Willebrand disease.
- Technological advancements: The development of novel technologies for the diagnosis and treatment of bleeding disorders is expected to drive the growth of the hemostasis diagnostics market in the coming years.
- Growing demand for point-of-care testing: The growing demand for point-of-care testing is another major factor that is expected to drive the growth of the global hemostasis diagnostics market in the next few years.
- Rising awareness about blood clotting disorders: There has been a rise in awareness about blood clotting disorders in recent years, which is likely to boost demand for hemostasis diagnostic products and services overthe forecast period . 5) Increasing number o f geriatric population :The increasing number o f geriatric population i s also anticipated t o fuel th e growth Hemostatis Diagnostic Market during th e forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostasis Diagnostics Market Research Report
By Type
Laboratory Analyzers, Point-of-Care Testing Systems
By Application
Hospitals, Diagnostic Centers, Others
By Companies
Abbott, Thermo Fisher Scientific, Roche, Nihon Kohden, Sysmex, Siemens Healthineers, Instrumentation Laboratory, Beckman Coulter, Grifols
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Hemostasis Diagnostics Market Report Segments:
The global Hemostasis Diagnostics market is segmented on the basis of:
Types
Laboratory Analyzers, Point-of-Care Testing Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Thermo Fisher Scientific
- Roche
- Nihon Kohden
- Sysmex
- Siemens Healthineers
- Instrumentation Laboratory
- Beckman Coulter
- Grifols
Highlights of The Hemostasis Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Laboratory Analyzers
- Point-of-Care Testing Systems
- By Application:
- Hospitals
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostasis Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostasis Diagnostics is a medical technology company that provides innovative diagnostic products and services to the healthcare industry. The company's products include hemostatic testing devices, including point-of-care tests for diagnosing blood clots and other vascular disorders. Hemostasis Diagnostics also offers consulting services to help healthcare providers improve their diagnosis and treatment of blood clots.
Some of the key players operating in the hemostasis diagnostics market are Abbott, Thermo Fisher Scientific, Roche, Nihon Kohden, Sysmex, Siemens Healthineers, Instrumentation Laboratory, Beckman Coulter, Grifols.
The hemostasis diagnostics market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hemostasis Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hemostasis Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hemostasis Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hemostasis Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hemostasis Diagnostics Market Size & Forecast, 2020-2028
4.5.1 Hemostasis Diagnostics Market Size and Y-o-Y Growth
4.5.2 Hemostasis Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Laboratory Analyzers
5.2.2 Point-of-Care Testing Systems
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hemostasis Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hemostasis Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Laboratory Analyzers
9.6.2 Point-of-Care Testing Systems
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Laboratory Analyzers
10.6.2 Point-of-Care Testing Systems
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Laboratory Analyzers
11.6.2 Point-of-Care Testing Systems
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Laboratory Analyzers
12.6.2 Point-of-Care Testing Systems
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Laboratory Analyzers
13.6.2 Point-of-Care Testing Systems
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hemostasis Diagnostics Market: Competitive Dashboard
14.2 Global Hemostasis Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Thermo Fisher Scientific
14.3.3 Roche
14.3.4 Nihon Kohden
14.3.5 Sysmex
14.3.6 Siemens Healthineers
14.3.7 Instrumentation Laboratory
14.3.8 Beckman Coulter
14.3.9 Grifols
